Some patients who experienced libido changes on semaglutide report improvement after switching to tirzepatide, though this is anecdotal rather than evidence-based
Anaesth Rep 2024;12:e12278.ArticlePubMedPMC 18
[1] No dosage adjustment is required for patients with renal impairment, including end-stage renal disease, though renal function should be monitored if severe gastrointestinal adverse effects occur
Furthermore, it reduces the risk of bone fracture and enhances cognition
Even though GLP-1 medications suppress appetite, its important to consume adequate protein, vitamins, minerals, and overall calories to support your health
Hu, W., Song, R., Cheng, R., Liu, C., Guo, R., Tang, W., Zhang, J., Zhao, Q., Li, X., & Liu, J